|
1
|
Dotan A, Muller S, Kanduc D, David P,
Halpert G and Shoenfeld Y: The SARS-CoV-2 as an instrumental
trigger of autoimmunity. Autoimmun Rev. 20(102792)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Liu Y, Sawalha AH and Lu Q: COVID-19 and
autoimmune diseases. Curr Opin Rheumatol. 33:155–162.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Feghali K, Atallah J and Norman C:
Manifestations of thyroid disease post COVID-19 illness: Report of
Hashimoto thyroiditis, Graves' disease, and subacute thyroiditis. J
Clin Transl Endocrinol Case Rep. 22(100094)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mizuno S, Inaba H, Kobayashi KI, Kubo K,
Ito S, Hirobata T, Inoue G, Akamizu T and Komiya N: A case of
postpartum thyroiditis following SARS-CoV-2 infection. Endocr J.
68:371–374. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mateu-Salat M, Urgell E and Chico A:
SARS-COV-2 as a trigger for autoimmune disease: Report of two cases
of Graves' disease after COVID-19. J Endocrinol Invest.
43:1527–1528. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jiménez-Blanco S, Pla-Peris B and
Marazuela M: COVID-19: A cause of recurrent Graves'
hyperthyroidism? J Endocrinol Invest. 44:387–388. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Harris A and AI Mushref MA: Graves'
thyrotoxicosis following SARS-CoV-2 infection. AACE Clin Case Rep.
7:14–16. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lanzolla G, Marcocci C and Marinò M:
Graves' disease and Graves' orbitopathy following COVID-19. J
Endocrinol Invest. 44:2011–2012. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bayar I, Tahri S, Hajji E, Ben AB, Sayadi
H, Héla M and Inès K: A case of Grave's disease following SARS-Cov
2 infection. Endocrine Abstracts. 73(AEP657)2021.
|
|
10
|
Khoury M, Tripathi P and Narayana S:
Abstract #1017450: COVID-19 Associated Grave's Disease Identified
in a 45-year-old Male. Endocrine Practice. 27:S186–S187. 2021.
|
|
11
|
Allam MM, El-Zawawy HT, Ahmed SM and Aly
Abdelhamid M: Thyroid disease and covid-19 infection: Case series.
Clin Case Rep. 9(e04225)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Qureshi NK and Bansal SK: Autoimmune
thyroid disease and psoriasis vulgaris after COVID-19 in a male
teenager. Case Rep Pediatr. 2021(7584729)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Montebello A: Recurrent Graves' disease
post SARS-CoV-2 infection. BMJ Case Rep. 14(e244714)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Marinò M, Latrofa F, Menconi F, Chiovato L
and Vitti P: Role of genetic and non-genetic factors in the
etiology of Graves' disease. J Endocrinol Invest. 38:283–294.
2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Duntas LH and Jonklaas J: COVID-19 and
thyroid diseases: A bidirectional impact. J Endocr Soc.
5(bvab076)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Croce L, Gangemi D, Ancona G, Liboà F,
Bendotti G, Minelli L and Chiovato L: The cytokine storm and
thyroid hormone changes in COVID-19. J Endocrinol Invest.
44:891–904. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rajaii F, McCoy AN and Smith TJ: Cytokines
as villains and potential therapeutic targets in thyroid-associated
ophthalmopathy: From bench to bedside. Expert Rev Ophthalmol.
9:227–234. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lania A, Sandri MT, Cellini M, Mirani M,
Lavezzi E and Mazziotti G: Thyrotoxicosis in patients with
COVID-19: The THYRCOV study. Eur J Endocrinol. 183:381–387.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Costela-Ruiz VJ, Illescas-Montes R,
Puerta-Puerta JM, Ruiz C and Melguizo-Rodríguez L: SARS-CoV-2
infection: The role of cytokines in COVID-19 disease. Cytokine
Growth Factor Rev. 54:62–75. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Murugan AK and Alzahrani AS: SARS-CoV-2
plays a pivotal role in inducing hyperthyroidism of Graves'
disease. Endocrine. 73:243–254. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Salvi M, Girasole G, Pedrazzoni M, Passeri
M, Giuliani N, Minelli R, Braverman LE and Roti E: Increased serum
concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in
patients with Graves' disease. J Clin Endocrinol Metab.
81:2976–2979. 1996.PubMed/NCBI View Article : Google Scholar
|
